Ionis Pharmaceuticals, Inc.
IONS
$55.34
-$0.68-1.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -114.65M | -92.53M | -229.39M | -128.61M | 123.55M |
| Total Depreciation and Amortization | 7.64M | 7.45M | 7.34M | 4.50M | 5.45M |
| Total Amortization of Deferred Charges | 1.80M | 2.35M | 1.97M | 1.65M | 1.65M |
| Total Other Non-Cash Items | 59.53M | 20.04M | 58.52M | -3.57M | 49.17M |
| Change in Net Operating Assets | 611.21M | -730.12M | 23.86M | -5.41M | -28.48M |
| Cash from Operations | 565.53M | -792.82M | -137.71M | -131.44M | 151.34M |
| Capital Expenditure | -16.08M | -21.76M | -21.29M | -5.27M | -12.31M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 39.58M | 558.58M | -398.21M | 96.61M | -107.76M |
| Cash from Investing | 23.50M | 536.82M | -419.51M | 91.34M | -120.07M |
| Total Debt Issued | -- | -- | 770.00M | -- | -- |
| Total Debt Repaid | -432.55M | -44.00K | -267.69M | -41.00K | -40.00K |
| Issuance of Common Stock | 20.26M | 57.30M | 107.82M | 81.26M | 1.29M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -18.95M | -- | -- |
| Cash from Financing | -412.29M | 57.26M | 591.18M | 81.22M | 1.25M |
| Foreign Exchange rate Adjustments | -50.00K | -138.00K | -43.00K | -82.00K | 595.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 176.68M | -198.88M | 33.92M | 41.04M | 33.11M |